According to this week's Bloomberg Businessweek (October 11, 2010), US officials are investigating whether a number of drug manufacturers including Merck, Bristol-Myers Squibb, AstraZeneca, Baxter, and GlaxoSmithKline, paid bribes to regulators and government-employed doctors to facilitate approval of the companies' pharmaceuticals. This action follows government settlements with a number of drug makers over improper marketing, including off-label use, of popular medications. The investigation is said to include activities in Brazil, China, Germany, Italy, Poland, Russia, and Saudi Arabia.
Comments
There are no comments for this post. Be the first and Add your Comment below.
Leave a Comment